Information for Radiologic Technologists
Questions about this year's conference? Call (802) 656-2292.
- Please register for the conference by 8:00 am on September 30, 2013. Walk-ins are welcome after the registration deadline. However, space is limited and some sessions may be closed. Register early!
- The conference will be held at the Sheraton Burlington Hotel & Conference Center in South Burlington, Vermont.
- The conference opens at 8:00 am with over 60 exhibits in the Exhibit Hall.
- Sessions begin at 9:00 am and end at 4:20 pm.
- The sessions and exhibits are free due to the generous support of the Susan G. Komen for the Cure Vermont-New Hampshire Affiliate, BlueCross BlueShield of Vermont, and Front Porch Forum.
ASRT credit has been approved for the 16th Annual Breast Cancer Conference.
Radiologic technologists should attend the following sessions to receive credit:
1-1 Adjuvant Therapy / Paul Unger, MD / This talk will cover the basic concept of giving treatments in addition to surgery for breast cancer patients. It will discuss the role of chemotherapy, hormonal, and immunological treatments for early stage breast cancer.
2-1 Breast Cancer and Weight Gain / Jean Harvey-Berino, PhD, RD / Weight gain is common in breast cancer patients after diagnosis. Unfortunately, survivors who are overweight are more likely to have their cancer recur than trimmer survivors. This workshop reviews why weight is likely to change during treatment and details activities you can do that have consistently been shown to reduce your risk of breast cancer, improve your odds of survival if you are diagnosed, and help prevent other illnesses.
2-6 Genetic Counseling and Testing / Wendy McKinnon, MS / This session reviews the features of hereditary breast and ovarian cancer and explains who might be a candidate for referral for genetic counseling and, possibly, genetic testing. The talk will review what happens during a genetic counseling session and discuss the risks, benefits, and limitations of undergoing genetic testing for cancer risk.
3-4 Genetic Testing and Inherited Breast and Ovarian Cancer: Patient Perspectives / Wendy McKinnon, MS / This panel discussion includes several individuals who have undergone genetic counseling and testing for the BRCA1/BRCA2 genes. These two genes are associated with the majority of inherited breast and ovarian cancers. There will be a variety of results and a range of perspectives on the testing process. Anyone interested in learning more about the BRCA1/BRCA2 counseling and testing process is encouraged to attend.
L-2 PHYSICIAN TRACK: Multidisciplinary Breast Cancer Care: A Mock Tumor Board Conference / Farrah Khan, MD, Deb Rubin, MD, Mary Stanley, MD, and Erin Tsai, MD / Every week cancer case presentations occur with all disciplines present, including surgery, medical oncology, radiation oncology, radiology, pathology, social services, research and plastic surgery. Cases are candidly discussed to solicit all opinions. These opinions are then conveyed to the patient when they differ at all from the care plan. This is a valuable teaching conference for all of the professionals involved and provides the patient a breadth of opinions regarding their care plan. This session is specifically geared toward primary care providers and other healthcare professionals.
4-5 What’s New in Breast Cancer Reconstruction? / Susan MacLennan, MD / In this session, we will focus on newer techniques for reconstruction after breast cancer surgery. Some of the techniques discussed may include oncoplastic surgery after lumpectomy, nipple sparing mastectomy, and new technologies that may improve reconstructive outcomes.
6-7 Tomosynthesis / Stephen Poplack, MD / Tomosynthesis is a method for performing high-resolution tomography at mammographic dose levels. This session will discuss how this process is changing the existing mammography field and how new research is developing.
6-13 Multi-Modality Approach in the Imaging of Women with Suspected Breast Cancer / Robert Oppenheimer, MD / The accurate diagnosis of both palpable and non-palpable abnormalities in women with suspected breast cancer often involves a multi-modality imaging approach to include mammography, tomosynthesis mammography, ultrasound and magnetic resonance imaging (MRI). Recent clinical cases with both benign and malignant results will be discussed to demonstrate the utility of a multimodality approach in diagnosis. There will be ample time at the end of the presentation for discussion and questions.
The cost of ASRT credit is $20.00. If you previously registered for the conference and wish to change your session and pay for credit, please call (802) 656-2292.
Last modified September 20 2013 10:15 AM